Synthetic hinge could hold key to revolutionary ‘smart’ insulin therapy
After nearly 9 million Pfizer shots for U.S. teens, serious side effects are rare, according to the CDC
2 August 2021Cryptic transcription in mammalian stem cells linked to aging
2 August 2021Synthetic hinge could hold key to revolutionary ‘smart’ insulin therapy
For people with diabetes who are insulin dependent, glycemic control is a full-time job. But what if their medication could do the work for them—an insulin whose activity in the bloodstream responds to the blood glucose levels and adjusts accordingly? An invention from Indiana University School of Medicine Distinguished Professor Michael A. Weiss, MD, Ph.D., could lead to just that.
